Table 2 Clinical characteristics of ICU survivors and interviewees
ICU survivors (n = 395) | Interviewees (n = 32) | |
|---|---|---|
Primary diagnosis, n (%) | ||
Infection/sepsis | 110 (27.8) | 6 (18.8) |
Trauma | 53 (13.4) | 4 (12.5) |
Respiratory failure | 43 (10.9) | 3 (9.4) |
Major bleeding1 | 38 (9.6) | 0 (0.0) |
Cardiac arrest | 24 (6.1) | 4 (12.5) |
GI diseases2 | 17 (4.3) | 3 (9.4) |
Liver failure | 16 (4.1) | 1 (3.1) |
Transplantation | 16 (4.1) | 3 (9.4) |
Postoperative | 16 (4.1) | 1 (3.1) |
Renal failure | 12 (3.0) | 3 (9.4) |
Pulmonary diseases3 | 10 (2.5) | 0 (0.0) |
Cardiac failure and/or myocardial infarction | 10 (2.5) | 2 (6.3) |
Vascular disorders4 | 10 (2.5) | 0 (0.0) |
Metabolic disorders | 8 (2.0) | 0 (0.0) |
Other | 7 (1.8) | 2 (6.3) |
Oncological or haematological disorders | 5 (1.3) | 0 (0.0) |
SAPS3 score | ||
Median (range) | 59 (16–100) | 57.5 (24–81) |
ICU, length of stay | ||
Days, median (range) | 5.5 (3.0–78.6) | 4.9 (1.7–76.1) |
Mechanical ventilation | ||
Patients, n (%) | 310 (78.5) | 23 (69.7) |
Days, median (range) | 5.0 (1.0–74.0) | 5 (1.0–62.0) |
Continuous renal replacement therapy | ||
Patients, n (%) | 88 (22.3) | 11 (33.0) |
Days, median (range) | 6.0 (1.0–42.0) | 8.0 (3.0–53.0) |